The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
Open accessAbstract
Autologous induced pluripotent stem cells (iPSCs) constitute an unlimited cell source for patient-specific cell-based organ repair strategies. However, their generation and subsequent differentiation into specific cells or tissues entail cell line-specific manufacturing challenges and form a lengthy process that precludes acute treatment modalities. These shortcomings could be overcome by using prefabricated allogeneic cell or tissue products, but the vigorous immune response against histo-incompatible cells has prevented the successful implementation of this approach. Here we show that both mouse and human iPSCs lose their immunogenicity when major histocompatibility complex (MHC) class I and II genes are inactivated and CD47 is over-expressed. These hypoimmunogenic iPSCs retain their pluripotent stem cell potential and differentiation capacity. Endothelial cells, smooth muscle cells, and cardiomyocytes derived from hypoimmunogenic mouse or human iPSCs reliably evade immune rejection in fully MHC-mismatched allogeneic recipients and survive long-term without the use of immunosuppression. These findings suggest that hypoimmunogenic cell grafts can be engineered for universal transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These gene-edited iPSCs could differentiate into endothelial cells and cardiomyocytes that demonstrated long-term survival in humanized mouse models without any immunosuppression.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [118]
The cited source says what the claim attributes to it.
In the citing paper
“Overexpression of CD47 has also been successfully implemented to mitigate innate immune responses after HLA deletion.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature reviews. Immunology · doi:10.1038/nri2017 · Cited by 1,393
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016) · Nature · doi:10.1038/nature19815 · Cited by 840
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Melkus, M. W., Estes, J. D., Padgett‐Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T., & Garcia, J. V. (2006) · Nature Medicine · doi:10.1038/nm1431 · Cited by 653
Self-citationHLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health
Arck, P., & Hecher, K. (2013) · Nature Medicine · doi:10.1038/nm.3160 · Cited by 609
Wunderlich, M., Chou, F.-S., Link, K. A., Mizukawa, B., Perry, R. L., Carroll, M., & Mulloy, J. C. (2010) · Leukemia · doi:10.1038/leu.2010.158 · Cited by 415
Chang, C., Fontes, J., Peterlin, M., & Flavell, R. (1994) · Journal of Experimental Medicine · doi:10.1084/jem.180.4.1367 · Cited by 352
Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bartunek, J., Marbán, E., Aßmus, B., Henry, T. D., Traverse, J. H., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304346 · Cited by 313
Cited by
Sorted by citations
Items 701–758 of 758
AlKhafaje, Z., Malathi, H., Dash, A., Precilla Selvakumari, J., Singh, G., Sinha, A., Suliman, M., & Smerat, A. (2026) · Regenerative Medicine · doi:10.1080/17460751.2026.2629846
Partridge, K., Mehler, V. J., Burns, C. J., Pober, J. S., & Moore, M. L. (2026) · Regenerative Medicine · doi:10.1080/17460751.2026.2631599
Heart Transplantation: A Review of Evolution, Current Status, and Persistent Challenges
Stegall, C. E., Ramaiah, C., & Akat, K. M. (2026) · International Journal of Angiology · doi:10.1055/a-2830-0203
Cell Therapy for Type 1 Diabetes Mellitus
Ghoneim, M. A., Refaie, A. F., & Gabr, M. M. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-12705-1_6
Cai, C., Liu, H., Liu, S., Zhao, Z., Xu, P., Wang, Y., Wang, J., Yakupu, A., Shao, J., Pan, M., et al. (2026) · Cells · doi:10.3390/cells15070631
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Mianné, J. (2020) · theses.fr (ABES) · doi:10.70675/179210b5z933bz4406zb297z7beef82bc3ae
Wang, T., Fang, H., Qi, L., Myoungseop, S., Khan, A., Gong, L., Zhou, G., Zhang, K., & Cui, H. (2026) · Advanced Science · doi:10.1002/advs.202521924
Targeting integrin αvβ3 by chimeric antigen receptor neural stem cell (CAR-NSC) therapy for strokePreprint
Rust, R., Weber, R., Rentsch, N. H., Buil, B. A., Habib, P., Bodenmann, C., Zürcher, K. J., Uhr, D., Meier, D., Generali, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.11.717950
Cellular reprogramming for reverse aging
Mishra, P. K., Ghosh, S., Singh, D. K. K., & Sinha, J. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00001-1
Usanova, A. A., Novikova, E. K., Петровна, С. Н., Kuzma, F., Vasilkova, A. S., & Alyamkin, S. Y. (2026) · Primary Health Care (Russian Federation) · doi:10.15829/3034-4123-2026-126
Zhang, Y., Xu, J., Shi, Y., Cai, Y., Gui, M., Xue, J., Zhou, X., Qin, Z., Chen, H., Liu, G., et al. (2026) · International Journal of Oral Science · doi:10.1038/s41368-026-00440-9
Nemilostiva, E. A., Paevskaya, O. A., Boymuradov, S., Safoyev, B., & Satov, M. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04396-4
Investigation of Neurotransplantation and Regenerative Therapy in Preclinical Models
Sugaya, K. (2026) · Contemporary clinical neuroscience · doi:10.1007/978-3-032-18296-8_28
Fiancette, R., Huang, J., Stephens, C., Hibbert, J. E., Hewitt, G., Carlein, C., Shilleh, A. H., Clinton, C., Osório, L. A., Tourigny, D. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.726825 · Cited by 1
Mangat, S., Tuomela, K., & Levings, M. K. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.05.017
Generation of therapeutic T cells from human induced pluripotent stem cells
Wang, B., & Kaneko, S. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00425-5
Brondeel, K. C., Sisti, A., & Branski, L. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-88389-4.00022-1
From autologous to universal Treg therapies
Plaisse, C., Bézie, S., & Guillonneau, C. (2026) · Trends Open · doi:10.1016/j.treopn.2026.05.005
Pulido, M., Báez-Díaz, C., Álvarez, V., Vázquez-López, F., Vives, J., Raya, Á., Casado, J. G., Sanchez-Margallo, F. M., Crisóstomo, V., & Lopez-Nieto, E. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1816404
Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy
Kang, S., & Lee, H. (2026) · Pharmaceuticals · doi:10.3390/ph19070991
Gene-Edited Stem Cells for Ischemic Vascular Disease: Current Advances and Future Perspectives
Han, S., & Kim, S.-W. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070681
Tomar, S., & Kumar, V. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12299-4
Press, C., Damour, K., Mamrak, N. E., Pepperl, D., Kutner, R. H., Colleluori, D. M., Graham, M. L., Brehm, M. A., Hussain, N., Latres, E., et al. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102998
Transient culture of adult human hepatocytes as organoids improves engineered liver engraftment
Saxton, S. H., Kang, I., Mitchell, S., Lotto, J., Upadhyay, A., Zou, C.-H., Quirk, C., McCray, T. N., Prado, O., Johansson, F., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124465
Kawaguchi, H. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2710868
Ekinci, N. S., & Arslan, H. S. (2026) · Human Immunology · doi:10.1016/j.humimm.2026.111814
Universal catalytic endothelial lineage nanovesicles for targeting and rescuing ischemic endothelium
Jiang, H., Wang, Y., Huang, H., Zhu, L., Shen, H., Jiang, L., Lin, C., Fang, H., Zheng, G., Shi, J., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102972
Guiding pluripotent stem cell therapies past the immune system
Pizzato, H. A., & Bhattacharya, D. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag051
Clinical landscape of human pluripotent stem cell-derived cardiomyocyte therapy
Mui, B. W. H., Neofytou, E. A., & Wu, J. C. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102962
Induced Pluripotent Stem Cell–Derived Natural Killer Cells: From Concept to Clinic
Casoni, G. P., & Malmberg, K. (2026) · Springer eBooks · doi:10.1007/978-3-662-68816-8_66-1
Marei, H. E. S. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05204-0
The evolution of iPSC-based cell therapy across autologous and allogeneic pathways
Wang, A., Zhang, Y., Deng, H., & Gu, M. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102992
Current Challenges and Future Perspectives of iPSC-Derived Cardiomyocytes
Tanaka, N., tsutsui, K., & Senbonmatsu, T. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016950
Hassanein, A., Cyprian, F., & Akhtar, S. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2721412
Cellular assemblies as living therapeutics
Gaspar, V. M., Almeida-Pinto, J., Moura, B. S., Cunha, A. F., Oliveira, M. B., Monteiro, M. V., & Mano, J. F. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-026-00470-2
Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine
Xu, H., Kamei, C., Gökbuget, D., DU, J. N., Barrero, M., Wang, L., Iwamoto, Y., Soriano, J. M., Godding, K., Wang, B., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.07.017
Induced pluripotent stem cells from discovery to translation
Lee, J., Herron, T. J., Studer, L., Mummery, C. L., & Wu, J. C. (2026) · Nature Medicine · doi:10.1038/s41591-026-04584-3 · Cited by 2
A synthetic NKG2A engager enables long-term persistence of HLA-deficient allogeneic engineered Tregs
Guo, T., Epstein, K. R., Hoover, M. E., Zammit, N. W., Yam, J. Y., Hussell, S., Hernandez, S., Doherty, A., Zarin, P., Sassone‐Corsi, M., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00507-4
Chen, Q., Jin, J., Kantawong, F., Li, G., & Li, J. (2026) · Vessel Plus · doi:10.20517/2574-1209.2026.69
Khalil, A. A. K., Büyüker, S. M., & Rahman, S. U. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06170-7
Kim, D., Choo, S., & Lee, S.-H. S. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70226
Feeling the tension: Engineered stem cells convert tumor stiffness into a drug target
Jiang, P., & Cheng, K. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.010
Jing, Z., Keisuke, S., Kanie, K., Akihiro, I., Yoshida, M., Tomoko, I., Bo, W., Shin, K., 0000002144, & 40361331 (2026) · Institutional Repositories DataBase (IRDB)
Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery
Johnson, B. B., Mummery, C. L., & Davis, R. P. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103079
Maeda, A., Han, X., & Mandai, M. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103053
HLA-Engineered iPSC-Derived Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Mice
Wei, Z., Gan, T., Liang, A.-N., Liu, S., Hao, J., Zou, W., Li, L., Mu, X.-M., Han, H.-T., Ma, W.-J., et al. (2026) · Cells · doi:10.3390/cells15191777
Cha, Y., & Kim, K. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103104
Chaudhry, K., Muniraj, N., Lang, H., Geiger, A. E., Paul, G., Dowlati, E., Sohai, D. K., Terao, J., Yadavilli, S., SANCHEZ, C., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10808000/v1
Human Organ and Tissue Transplantation: A New Step in Evolution?
Legach, E. E., Globa, V., & Legach, E. I. (2026) · Springer eBooks · doi:10.1007/978-981-95-9585-3_9
Citro, A., & Piemonti, L. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1943061
Emerging stem cell strategies for neurodegenerative diseases
Hardjo, M., & Sophian, A. (2026) · Transplant Immunology · doi:10.1016/j.trim.2026.102465
Engineering monocytes and macrophages for therapeutic control
Chen, Y., Brown, C. E., Shi, Y., & Feng, M. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.09.009
Antonov, D., Loguinova, M. Y., Fan, H., Sazonova, E. V., Sosnovtseva, A. O., Karpov, D. S., Molchanov, A. D., Nikolenko, V. N., Chekhonin, V. P., & Mokrysheva, N. G. (2026) · Cells · doi:10.3390/cells15201902
Cell Transplantation for Skeletal Muscle Regeneration: Current Strategies and Clinical Translation
Cinemre, D. A., Cinemre, G. C., Rozmukhamedova, S., Arunchander, T., Gharaibeh, B., & Deasy, B. M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016937
Leavens, C. M., Chamberlain, C. S., Kapadia, D., Jurrens, N., Estrada, E. J., Talerico, K., Arroyo, M., -, P. D., & Odorico, J. S. (2026) · Regenerative Medicine · doi:10.1080/17460751.2026.2751695
Che, X., Jin, X., Lee, D.-K., Park, M. S., Kim, Y., Kim, H.-J., Kim, H.-J., & Choi, J. (2026) · Organoid · doi:10.51335/organoid.2026.6.e12
Ito, M., Tsuzuki, H., Secinaro, M. A., Kreuser, S. A., Oda, K., Kheng, B., Galitan, L., Vergara, J., Takeuchi, I., Ameny, S. L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1938206
Metadata
- Authors
- Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., Davis, M. M., Lanier, L. L., & Schrepfer, S.
- Affiliations
- University of California, San Francisco (US)
- Universität Hamburg (DE)
- University of North Carolina at Chapel Hill (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Schrepfer, Sonja
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2019-02-18
- Volume
- 37
- Issue
- 3
- Pages
- 252-258
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC6419516
- OpenAlex
- W2911604931
- Cited by
- 758
- References
- 31
- Citations by year
- 2026: 98 · 2025: 102 · 2024: 102 · 2023: 113 · 2022: 94 · 2021: 97 · 2020: 106 · 2019: 46
- FWCI
- 28.36
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-09-16)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL140236)
- National Institute of Mental Health (R01MH108179)
- National Institute of Allergy and Infectious Diseases (R01AI068129, R01AI111899, R01AI123010, U19AI057229)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, immune rejection, allogeneic transplantation, MHC mismatch, endothelial cells, smooth muscle cells, cardiomyocytes, immunosuppression-free transplantation
- MeSH terms
- Animals, Cell Differentiation, Graft Rejection, HLA Antigens, Humans, Transplantation, Homologous, Histocompatibility Antigens Class I, Myocytes, Cardiac, Mice, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
